General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Why Rivian Stock Investors Need Nerves of Steel Amid Mixed Outlook | news.google.com • |
The US Stock Market's Outlook: Further Gains in 2024 Mainly Dependent on Rate Cuts? | news.google.com • |
Salesforce Shares Plunge by Most Since 2008 After Weak Outlook | news.google.com • |
Nutanix Stock: Earnings Beat, While Revenue Outlook Misses. Shares Tumble | news.google.com • |
Salesforce Stock Plunges on Q1 Revenue Miss, Soft Outlook | news.google.com • |
Kohl’s Q1 Earnings: Revenue And Profit Miss, Outlook Cut, Stock Tumbles Why Department Store Chain Kohl's | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-15 | 2024-03 | -0.88 | -1.55 | -0.67 | -76.14% |
2024-02-14 | 2023-12 | -1 | -0.8 | 0.2 | 20.00% |
2023-12-22 | 2023-09 | -1 | -1 | N/A | N/A |
2023-08-14 | 2023-06 | -0.8 | -1.6 | -0.8 | -100.00% |
2023-05-15 | 2023-03 | -1.2 | -0.6 | 0.6 | 50.00% |
2023-02-14 | 2022-12 | -0.8 | -1.6 | -0.8 | -100.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-30 | Chardan Capital | Downgrade | Buy | Neutral |
2023-08-30 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2023-08-29 | Brookline Capital | Downgrade | Buy | Hold |
2023-08-29 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
2023-08-29 | BTIG | Downgrade | Buy | Neutral |
2023-08-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-04-19 | DAGNON TERRY | Chief Operating Officer | 653.06K | Sale |
2024-03-06 | EVANSON JEFF | Officer | 808.46K | Purchase |
2024-03-27 | HADDADIN YEZAN MUNTHER | Director | 5.05K | Purchase |
2022-10-04 | HILZINGER KURT J | Director | 473.12K | Purchase |
2021-04-19 | KENYON LAWRENCE A. | Chief Executive Officer | 18.93K | Purchase |
2022-10-06 | SUKHTIAN FAISAL GHIATH | Director | 68.00K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 9.22M | 16.04M | 3.54% |
2023-06-29 | Vanguard Group Inc | 6.15M | 10.70M | 2.36% |
2023-06-29 | State Street Corporation | 2.75M | 4.79M | 1.06% |
2023-06-29 | Geode Capital Management, LLC | 2.72M | 4.73M | 1.05% |
2023-06-29 | Northern Trust Corporation | 1.26M | 2.18M | 0.48% |
2023-06-29 | Nuveen Asset Management, LLC | 598.96K | 1.04M | 0.23% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 3.61M | 6.28M | 1.39% |
2023-08-30 | iShares Russell 2000 ETF | 3.58M | 815.24K | 1.37% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.45M | 2.52M | 0.56% |
2023-07-30 | Fidelity Small Cap Index Fund | 1.38M | 2.38M | 0.53% |
2023-08-30 | iShares Russell 2000 Growth ETF | 1.27M | 289.29K | 0.49% |
2023-05-30 | Fidelity Extended Market Index Fund | 519.75K | 779.62K | 0.20% |
Split | Date |
---|---|
1 : 20 | 2024-03-14 |
1 : 8 | 2019-03-18 |
Alex,
Delusion is optional and I think it’s going to be substantially less than you think delusion is optional. It is going to be substantially less than you think. With approval in hand and European contracts in hand. A short term operating loan would less expensive with less new share holders.
Another great buying day! The shorts are giving all their money away. They can keep selling otlk but they won't be able to buy any. I don't usually lend my shares but I'm thinking of give the shorts enough rope to do the job. Like I said, this is a get day to buy, buy, buy…
The shorts are going through the roof!!! I ️ a good short squeeze. It just warms my heart.
We have exclusive approval and way more cash than we need to get to market. Europe is a multi billion market already using this product. These patient need the replacement for off label compounding ASAP. Do you really think the can wait until next year??? Statement of 2025 is just underpromising as to not getting sued. OTLK will over deliver being pushed by demand.
Buying, buying, buying… I love deals!
If you are dumb enough to sell now…. You clearly don't belong on the stock market. After you sell stamp yourself stupid and go find a broker.
We are on the money!!!!! The billion dollar premade make is ours and at what a price.
How exciting!!! We are about yo see a run on the shorts. We have all heard about it. We have all talked about it….. No you are going to see it!!!!
Its going to be epic.
Franca, i think you meant to say $20 plus by May 27th. I think you you will find most analystswould agree that with approval $60-100 is more likely by end of year. Unlike other medications coming to market we already have a built in market already worth billions. This is a wholly unique opportunity that doesn’t come around very often if ever
Saltytimtation- off label gets no protection. The new medication will be pure and of standardized strength/potency. There will be no one wiling to compound off-label because of patent infringement. No providers will write off label for fear of medical malpractice. Insurance companies will not pay for it or insure providers that write it. To put it simple that even with the price increase.… this will be the cheapest and safest treatment available. Compounding off label will no longer exist which means 100% capture of that market.
Short ratio has grown from .68 to 3.24. Day traders and shorts are playing with the price, do not be fooled. This is truly not the accurate (future) price of this stock…. The 28th of May is near. Keep the faith. Any day is a possible approval…. I would be a nervous Nelly if I was trading short.
It may be that the system is capable of beating this one down… so it is doing it. Remember EMA and FDA want this medication approved so it stops: compounding, impurities, particulates, and lack of drug potency. I appreciate/capitalizing on the bargain pricing.